Parenteral Formula Market to Reach US$ 12.5 Billion by 2034 Amid Rising Prevalence of Cancer, AIDS, and Diabetes [Yahoo! Finance]
Baxter International Inc. (BAX)
Last baxter international inc. earnings: 4/30 07:15 am
Check Earnings Report
US:NYSE Investor Relations:
investor.baxter.com
Company Research
Source: Yahoo! Finance
a surge due to rising malnutrition and preterm births worldwide (2024-2034). The report offers a comprehensive analysis to help you capitalize on this trend, including market drivers, potential challenges, and exciting opportunities. It even provides investment insights and strategic decision-making tools. According to a recent Future Market Insights (FMI) report, sales of parenteral formula are expected to reach a value of US$ 12.5 billion by 2034. The market is anticipated to rise at a CAGR of around from 2024 to 2034. It is estimated to attain a value of US$ 6.8 billion by 2024. Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-19343 The high prevalence of chronic diseases worldwide is a key factor propelling the parenteral formulation industry. Parenteral formulation consumption has increased recently due to the rising prevalence of short bowel syndrome, cancer, AIDS, diabetes, Crohn's disease
Show less
Read more
Impact Snapshot
Event Time:
BAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAX alerts
High impacting Baxter International Inc. news events
Weekly update
A roundup of the hottest topics
BAX
News
- Anti-Adhesion Products Market Projected to Reach $1.69 billion by 2030 - Exclusive Report by 360iResearch [Yahoo! Finance]Yahoo! Finance
- Tentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEO [Yahoo! Finance]Yahoo! Finance
- Kidney Dialysis Equipment and Supplies Global Strategic Market Report 2023-2030: Synthetic Dialyzers Emerge As Mainstay Tools, Increasing Penetration of Single-Use Dialyzers [Yahoo! Finance]Yahoo! Finance
- Global Parenteral Nutrition Bags Market Analysis Report 2024-2031: Growth in Single-Chamber Solutions and Increased Adult Consumer Segment Bolsters Growth [Yahoo! Finance]Yahoo! Finance
- Baxter's (BAX) New Injectables Aid Its Pharmaceutical Portfolio [Yahoo! Finance]Yahoo! Finance
BAX
Earnings
- 2/8/24 - Beat
BAX
Sec Filings
- 3/27/24 - Form DEFA14A
- 3/25/24 - Form DEFA14A
- 3/25/24 - Form DEF
- BAX's page on the SEC website